Strides Arcolab has received approval from the United States Food & Drug Administration (USFDA) for Buspirone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg and 30 mg. Buspirone Tablets are used for the treatment of anxiety disorders and the short-term relief of the symptoms of anxiety.
The US market for generic Buspirone Tablets is around $65 million. The product will be manufactured at the company’s Oral dosage facility at Bangalore and marketed directly by Strides in the US Market.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
